Skip to content

Epidemiological Investigation of Exercise - Induced Bronchoconstriction among Elite Athletes in Chongqing

Epidemiological Investigation of Exercise - Induced Bronchoconstriction among Elite Athletes in Chongqing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120102
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-Induced Bronchoconstriction,EIB

Interventions

Observation group:none

Sponsors

The Affiliated Rehabilitation Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Athletic qualification shall be at or above the national first-class level. 2.Professional training duration shall be no less than 5 years. 3.Weekly training time shall be no less than 15 hours.

Exclusion criteria

Exclusion criteria: 1. Suffering from chronic obstructive pulmonary disease (COPD), cor pulmonale, depression, or other major diseases; 2. Having undergone thoracic surgery; 3. Having had a pulmonary infection within 3 weeks prior to the experiment; 4. Having suspended training for 2 weeks or more before the experiment; 5. Having experienced moderate or severe symptoms such as colds and respiratory infections within 1 week prior to the experiment.

Design outcomes

Primary

MeasureTime frame
Forced Expiratory Volume in 1 second,FEV1;Forced Vital Capacity,FVC;Forced Expiratory Volume in one second/Forced Vital Capacity,FEV1/FVC ratio;Maximal Voluntary Ventilation,MVV;Peak Expiratory Flow,PEF;Absolute Neutrophil Count,ANC;Absolute Eosinophil Count,AEC;Absolute Basophil Count,ABC;Absolute Lymphocyte Count,ALC;White Blood Cell Count,WBC;Prostaglandin E2,PGE2;Club Cell Secretory Protein-16,CC16;Progesterone,P;Cortisol,C;Vital Capacity,VC;

Secondary

MeasureTime frame
Interleukin-6,IL-6;Interleukin-8,IL-8;Tumor Necrosis Factor-a,TNF-a;

Countries

China

Contacts

Public ContactLingMin Li

The Affiliated Rehabilitation Hospital of Chongqing Medical University

1534176875@qq.com+86 159 3410 1446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026